A key opinion leader discusses effective risk prevention measures and challenges to reducing adverse events. He also considers effective educational resources for self-care.
Persistent Statin Use Shows Increase of Risk Diabetes for Obstructive Sleep Apnea, Hypertension Patients
Hypertension and obstructive sleep apnea are considered independent risk factors for cardiovascular diseases as well as diabetes.
How Barbershops Are Becoming Community Health Care Destinations
The Cut Hypertension Program operates in barbershops across the Bay Area in California. The program’s lead pharmacist joined us to discuss main themes and goals of the new initiative.
Mobile Health Technologies to Change Landscape of Cardiovascular Health
Technology, such as continuous glucose monitors, changes the way patients are treated, but more work needs to be done for racial, ethnic, and socioeconomic disparities.
Effects of Long COVID on Heart Health Remain Unknown
Pharmacists can help manage complications from long COVID-19, as no medications can treat it.
Sotatercept Reduces Risk of Major Morbidity, Mortality for Pulmonary Arterial Hypertension
Patients with pulmonary arterial hypertension (PAH) received the maximum tolerated dose of background therapy with sotatercept or the placebo to the therapy.
FDA Approves Vutrisiran For Adult Patients With ATTR-CM
The decision makes the RNAi therapeutic the only therapy approved by the FDA to treat ATTR-CM and hATTR-PN.